文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

阿富汗2级救治机构烧伤伤员特征分析

Characteristics of burn casualties treated at role 2 in Afghanistan.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论阿富汗2级救治机构收治的烧伤伤员中位烧伤面积11%、27.2%合并吸入性损伤,需大量操作,2级机构死亡率1.5%。

该研究基于国防部创伤登记库,纳入2005年10月至2018年4月在阿富汗2级救治机构接受治疗的453例烧伤伤员,排除仅有一度烧伤、未特指烧伤或仅角膜烧伤者。伤员中位损伤严重度评分10、中位烧伤面积11%,27.2%有吸入性损伤,共需2530次操作;有复苏记录者中位接受1.9 L晶体液。并发症发生率11.7%,最终死亡率8.0%,2级机构内死亡率1.5%。研究提示2级机构需保障气道管理、复苏和创面护理相关物资。

要点

  • 纳入453例在阿富汗2级救治机构治疗的烧伤伤员,中位烧伤面积11%(IQR 5-30),中位损伤严重度评分10(IQR 4-22)。
  • 27.2%(123例)合并吸入性损伤,提示2级机构需具备气道管理能力与相应物资。
  • 有复苏记录者中位接受1.9 L(IQR 0.7-3.7)晶体液,原文未给出具体复苏方案或目标。
  • 并发症见于11.7%(53例),最终死亡率8.0%(36例),2级机构内死亡率1.5%(7例)。
  • 伤员共需2530次操作,涵盖气道管理、复苏和创面护理,物资保障是2级机构准备重点。

适用人群与场景

  • 2005年10月至2018年4月在阿富汗2级救治机构接受治疗并有记录的烧伤伤员。
  • 排除仅有first-degree burns、not otherwise specified burns或仅corneal burns的伤员。

诊断标准与关键阈值

  • 纳入标准:(1)2005年10月至2018年4月在阿富汗发生烧伤;(2)DODTR中有在role 2接受治疗的记录。
  • 排除标准:仅有first-degree burns、not otherwise specified burns或仅corneal burns。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为基于国防部创伤登记库(DODTR)的流行病学研究,证据等级III;样本量453例烧伤伤员,未报告中心数。
  • 人群:阿富汗2级救治机构收治的烧伤伤员,中位ISS 10(IQR 4-22),中位烧伤面积11%(IQR 5-30)。
  • 27.2%(123例)合并吸入性损伤;伤员共有3343处额外创伤,需2530次操作。
  • 有复苏记录者中位晶体液量1.9 L(IQR 0.7-3.7);并发症53例(11.7%)。
  • 最终死亡36例(8.0%),2级救治机构内死亡7例(1.5%)。

证据类型、等级与局限

  • 证据类型:流行病学研究,原文标注证据等级III。
  • 局限:基于登记库的回顾性研究,部分伤员复苏信息缺失(原文仅报告有记录者的液体量);原文未报告中心数;作者指出需更多关于患者救治环境的背景信息。

对床旁实践的改变

  • 提示2级救治机构应保障气道管理、复苏和创面护理所需设备与物资,因烧伤伤员操作需求量大(2530次操作/453例)。
  • 烧伤伤员常合并多发伤(3343处额外创伤),评估时需关注合并损伤对复苏的影响(原文提及损伤严重度、合并创伤和可用物资可能影响复苏)。
  • 原文未提供具体复苏方案、药物剂量或操作流程,不能据此改变具体临床处置。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Role 2 medical treatment facilities (MTFs) are frequently located in austere settings and have limited resources. A dedicated assessment of burn casualties treated at this level of care has not been performed. Therefore, the objective of this study was to characterize burn casualties presenting to role 2 MTFs in Afghanistan, along with the procedures they required, complications, and mortality to begin understanding the resources consumed by their care.

METHODS: We identified burn casualties from the Department of Defense Trauma Registry (DODTR). The inclusion criteria were (1) experienced burn injuries in Afghanistan between October 2005 and April 2018 and (2) had documentation of treatment at role 2 in the DODTR. We excluded casualties with only first-degree burns, not otherwise specified burns, or only corneal burns. Casualty demographics, injury characteristics, procedures, and outcomes were reported.

RESULTS: We identified 453 burn casualties with a median (interquartile range) Injury Severity Score of 10 (4-22) and percent total body surface area burned of 11 (5-30). There were 123 casualties (27.2%) with inhalation injury, and the casualties experienced 3,343 additional traumatic injuries and needed 2,530 procedures. Casualties with documentation of resuscitation information received a median (interquartile range) of 1.9 (0.7-3.7) L of crystalloid fluids. Complications were documented in 53 casualties (11.7%). Final mortality was reported in 36 casualties (8.0%), and mortality at role 2 MTFs was reported in 7 casualties (1.5%).

CONCLUSION: Burn casualties had many injuries and needed many procedures, including those related to airway management, resuscitation, and wound care. Given the urgency of these procedures, ensuring that there is enough equipment and supplies will be important in the future. Although infrequent, some casualties experienced complications. Factors that may influence resuscitation include injury severity, concomitant traumatic injuries, and available supplies. Obtaining more contextual information on the patient care environment will be useful going forward.

LEVEL OF EVIDENCE: Epidemiological, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Suresh MR, Staudt AM, Trevino JD, et al. Characteristics of burn casualties treated at role 2 in Afghanistan. J Trauma Acute Care Surg. 2021. PMID: 34324475. doi:10.1097/TA.0000000000003161

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。